Front Line Genomics shared on LinkedIn:
“Working on liquid biopsy?
Join Cancer Diagnostics ONLINE – Turning Data into Decisions to explore how to get more useful information from your samples and what it takes to turn that information into clinical value.
This is a three-part webinar series.
Across these webinars, you’ll gain insights to help you:
- Choose biomarkers, biofluids and assays that fit your research question.
- Understand where tumor signals are lost and how sample processing and enrichment can improve detection.
- Assess the evidence needed to move a promising assay towards clinical use.
Hear practical examples spanning pediatric cancers, scarce ctDNA, methylation and multimodal biomarkers from:
- Catherine Alix-Panabières, Professor of Oncology and Director of the Laboratory of Rare Human Circulating Cells, University of Montpellier
- Klaus Pantel, Director of the Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf (UKE)
- Yassmine Akkari, PhD, Senior Director, Institute for Genomic Medicine, Nationwide Children’s Hospital
- Liana Nobre, Assistant Professor, University of Alberta
- Daniel Hagey, Assistant Professor, Karolinska Institute
- Shervin Tabrizi, Assistant Professor of Radiation Oncology, University of Pennsylvania
- Guro Elisabeth Lind, Professor of Epigenetics, Oslo University Hospital
- Dominic G. Rothwell, Deputy Director, CRUK National Biomarker Centre
17 & 24 November and 1 December
3pm GMT | 4pm CET | 10am EST
Register once for all three sessions.”
To which, Catherine Alix-Panabières, Professor of Oncology at University of Montpellier, added:
“Delighted to open the Webinars with the first lecture on ‘The Evolving Landscape of Liquid Biopsy in Oncology‘!
Please register and see you very soon.”

You can also read: Liquid Biopsy and ctDNA After Cancer Treatment: Can ctDNA Detect Cancer Recurrence Before Scans?
